Topical photodynamic therapy of murine non-melanoma skin carcinomas with aluminum phthalocyanine chloride and a diode laser: Pharmacokinetics, tumor response and cosmetic outcomes

Photodermatology Photoimmunology and Photomedicine

Volumn 24, Issue 2, 2008, Pages 87-94

  Kyriazi, Maria ^a   Alexandratou, Eleni ^a   Yova, Dido ^a   Rallis, Michail ^b   Trebst, Tilmann ^c  

^a NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c CeramOptec GmbH   (Germany)

Author keywords

Aluminum phthalocyanine chloride; Non melanoma skin carcinomas; Photodynamic therapy; Topical administration

Indexed keywords

PHTHALOCYANINE ALUMINUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER REGRESSION; CONTROLLED STUDY; DIODE LASER; DRUG ABSORPTION; DRUG EFFICACY; DRUG PENETRATION; DRUG RESPONSE; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; ESTHETICS; FEMALE; LOW LEVEL LASER THERAPY; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN CARCINOMA; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ANIMALS; CARCINOMA, BASAL CELL; FEMALE; INDOLES; MALE; MICE; MICE, INBRED STRAINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS;

EID: 41149173752     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2008.00345.x     Document Type: Article

References (28)

1. Kubler A. Photodynamic therapy. Med Laser Appl 2005; 20: 37-45.
2. Hopper C. Photodynamic therapy: A clinical reality in the treatment of cancer. Lancet Oncol 2000; 1: 212-219.
3. Stylli S, Kaye A. Photodynamic therapy of cerebral glioma - a review Part I - a biological basis. J Clin Neurosci 2006; 13: 615-625.
4. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000; 42: 389-413.
5. Zeitouni N, Oseroff A, Shieh S. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Mol Immunol 2003; 39: 1133-1136.
6. Moriwaki SI, Misawa J, Yshimari Y, Yamada I, Takigawa M, Tokura Y. Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin ™). Photodermatol Photoimmunol Photomed 2006; 17: 241-243.
7. Bilgin M, Elcin E, Elcin M. Topical use of liposomal copper palmitate formulation blocks porphyrin-induced photosensitivity in rats. J Photochem Photobiol 2005; 80: 107-114.
8. Bellnier D, Greco W, Nava H, Loewen G, Oseroff A, Dougherty T. Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy. Cancer Chemother Pharmacol 2006; 57: 40-45.
9. Castano A, Demidova T, Hamblin M. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther 2004; 1: 279-293.
10. Detty M, Gibson S, Wagner S. Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Med Chem 2004; 47: 3897-3915.
11. Wilson A, Malham G, Thomsen R, Harvey J, Baguley B. Determination of the activation spectrum of aluminum phthalocyanine chloride against culture meningioma cells using a tunable laser. J Clin Neurosci 1996; 3: 252-256.
12. Kaestner L, Cesson M, Kassab K, et al. Zinc octa- n -ethyl phthalocyanines in photodynamic therapy: Photophysical properties, accumulation and apoptosis in cell cultures, studies in erythrocytes and topical application to Balb/c mice skin. Photochem Photobiol Sci 2003; 2: 660-667.
13. Kalka K, Ahmad N, Criswell T, Boothman D, Mukhtar H. Up-regulation of clusterin during phthalocyanine 4 photodynamic therapy-mediated apoptosis of tumor cells and ablation of mouse skin tumors. Cancer Res 2000; 60: 5984-5987.
14. Agarwal R, Athar M, Elmets CA, Bickers DR, Mukhtar H. Photodynamic therapy of chemically- and ultraviolet B radiation-induced murine skin papillomas by chloroaluminum phthalocyanine tetrasulfonate. Photochem Photobiol 1992; 56: 43-50.
15. National Cancer Institute, Clinical trials, Photodynamic therapy using silicon phthalocyanine 4 in treating patients with actinic keratosis, Bowen's disease, skin cancer, or stage I or II mycosis fungoides. http://www.clinicaltrials.gov/ct/gui/show/NCT00103246, Copyright 2006.
16. National Cancer Institute, Clinical trials, Photodynamic therapy in treating patients with skin cancer or solid tumors metastatic to the skin. http://www.clinicaltrials.gov/ct/gui/show/NCT00023790, Copyright 2006.
17. Kyriazi M, Yova D, Rallis M, Lima A. Cancer chemopreventive effects of Pinus Maritima bark extract on ultraviolet radiation and ultraviolet radiation-7,12,dimethylbenz(a)anthracene induced skin carcinogenesis of hairless mice. Cancer Lett 2006; 237: 234-241.
18. Masumoto K, Yamada I, Tanaka H, Fujise Y, Hashimoto K. Tissue distribution of a new photosensitizer ATX-S10Na(II) and effect of a diode laser (670 nm) in photodynamic therapy. Lasers Med Sci 2003; 18: 134-138.
19. Ronn A, Batti J, Lee C, et al. Comparative biodistribution of meta-tetra (hydroxyphenyl) chlorin in multiple species: Clinical implications for photodynamic therapy. Lasers Syrg Med 1997; 20: 437-442.
20. Williams A, Barry B. Penetration enhancers. Adv Drug Deliver Rev 2004; 56: 603-618.
21. Duimel-Peters I, Houwing RH, Teunissen CP, Berger MPF, Snoeckx LH, Halfens RJG. A systemic review of the efficacy of topical skin application of dimethyl sulfoxide on wound healing and as an anti-inflammatory drug. Wounds 2004; 15: 361-370.
22. Basketter D, York M, McFadden JP, Robinson MK. Determination of skin irritation potential in the human 4-h patch test. Contact Dermat 2004; 51: 1-4.
23. Bellnier D, Greco W, Loewen G, Nava H, Oseroff A, Dougherty T. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (photochlor) and 5-ALA-induced Protoporphyrin IX. Lasers Surg Med 2006; 38: 439-444.
24. Bossu E, Padilla-Ybarra JJ, Notter D, Vigneron C, Guillemin F. Determination of the maximal carcinoma/normal skin ratio after HpD or m-THPC administration in hairless mice (SKH-1) by fluorescence spectroscopy. Anti Cancer Drugs 2000; 11: 85-91.
25. Scarmato De Rosa F, Maldonado Marchetti J, Thomazini JA, Tedesco AC, Lopes MV, Bentley B. A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulfoxide on 5-aminolevulenic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J Control Release 2000; 65: 359-366.
26. Veenhuizen R, Stewart F. The importance of fluence rate in photodynamic therapy: Is there a parallel with ionizing radiation dose-rate effects? Radiother Oncol 1995; 37: 131-135.
27. Sieron A, Kawcsyk-Krupka A, Adamek M, et al. Photodynamic therapy (PDT) using topically applied δ-aminolevulinic avid (ALA) for the treatment of malignant skin tumors. Photodiagn Photodyn Ther 2004; 1: 311-317.
28. Baptista J, Martinez C, Leite L, Cochito M. Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years. J Eur Acad Dermatol Venereol 2006; 20: 693-697.